Metraipolis › archive › dc_e5e0b526fa17

Toward Personalized ACS Therapy: How Disease Status and Patient Lifestyle Shape the Molecular Signature of Autologous Conditioned Serum — Europe PMC PMID:41682693

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41682693
DOI
10.3390/jcm15031014
License (as archived)
solo-consultazione
Archived
2026-11-06T12:08:22.199Z
SHA-256 of the archived text
57c9707083354f8d959655c53069983e67d13b0adf9fa964939c362763ab0c92
Stable URL of this page
https://metraipolis.com/documento/dc_e5e0b526fa17

How to cite

Toward Personalized ACS Therapy: How Disease Status and Patient Lifestyle Shape the Molecular Signature of Autologous Conditioned Serum — Europe PMC PMID:41682693 — Europe PMC (en), https://europepmc.org/article/MED/41682693 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e5e0b526fa17 (Metraipolis archive dc_e5e0b526fa17, sha256 57c9707083354f8d959655c53069983e67d13b0adf9fa964939c362763ab0c92)
BibTeX
@misc{dce5e0b526fa17,
  title = {Toward Personalized ACS Therapy: How Disease Status and Patient Lifestyle Shape the Molecular Signature of Autologous Conditioned Serum — Europe PMC PMID:41682693},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41682693},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e5e0b526fa17; sha256 57c9707083354f8d959655c53069983e67d13b0adf9fa964939c362763ab0c92},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41682693. Agents can read the archived copy with the MCP tool read_document.